PPG Industries (NYSE:PPG) today announced the completion of the
previously announced cash tender offers (each an “Offer”) for any and
all of its outstanding debt securities in the series specified in the
table below (the “Securities”). Each Offer expired at 5:00 p.m., New
York City time, on November 14, 2014.
Fantex Brokerage Services, LLC has opened the reservation period for
Fantex Series Alshon Jeffery Convertible Tracking Stock 1
(OTC:JEFFL). Starting today, eligible investors can place reservations
for shares at Fantex.com. 2 Fantex, Inc. is offering 835,800
shares of Fantex Alshon Jeffery at a price of $10 per share.
CPSI (NASDAQ: CPSI), a leading provider of health information systems
and services, and its wholly owned subsidiary, TruBridge, today
announced that they are leveraging IBM technology to develop and deliver
predictive analytics to rural and community hospitals.
Inc. (NYSE:MET) and Fidelity
Investments ® today announced the introduction of a new
deferred variable annuity product that provides investors both growth
potential and protection against loss if held for a minimum of 10 years.
Inc. (NYSE: MDT) and Covidien plc
(NYSE: COV) announced that following a hearing today before the Irish
High Court the companies have scheduled shareholder meetings for
Tuesday, January 6, 2015, in connection with the pending acquisition of
Covidien by Medtronic.
Humana Inc. (NYSE: HUM) will offer health insurance as a Qualified
Health Plan insurer on the individual market public exchanges through
the Affordable Care Act (ACA), also known as Marketplaces, in 15 states
Evaluation based on completeness of vision and ability to execute RA'ANANA, Israel , November 17, 2014 /PRNewswire/ --
NICE Systems (NASDAQ: NICE) today announced it has been positioned by Gartner, Inc. in the "leaders" quadrant of the "2014 Magic Quadrant for Customer Engagement Center Workforce Optimization."  NICE was recognized by Gartner for its completeness of vision and ability to execute, based on the criteria listed in the report.
Sign-up for Multi-Center Comparative Study Of MiMedx EpiFix® And Organogenesis Apligraf® Determines EpiFix Has Considerably Higher Rates Of Complete Healing And Significantly Faster Time To Heal investment picks
KANSAS CITY, MO--(Marketwired - November 17, 2014) - H&R Block Inc. (NYSE: HRB) will report fiscal 2015 second quarter results after the New York Stock Exchange market close on Monday, December 8.
Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
company, announced today that it has presented new pre-clinical data
from its investigational RNAi therapeutic programs toward genetically
validated targets in development for the treatment of cardiovascular
metabolic diseases, including: ALN-PCSsc targeting PCSK9 for the
treatment of hypercholesterolemia; ALN-AC3 targeting apolipoprotein C3
(apoC3) for the treatment of hypertriglyceridemia; and ALN-ANG targeting
angiopoietin-like 3 (ANGPTL3) for the treatment of genetic forms of
mixed hyperlipidemia and severe hypertriglyceridemia.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.